CU23884B1 - DERIVATIVES OF DIBENZOTIAZEPINA - Google Patents

DERIVATIVES OF DIBENZOTIAZEPINA

Info

Publication number
CU23884B1
CU23884B1 CU20100252A CU20100252A CU23884B1 CU 23884 B1 CU23884 B1 CU 23884B1 CU 20100252 A CU20100252 A CU 20100252A CU 20100252 A CU20100252 A CU 20100252A CU 23884 B1 CU23884 B1 CU 23884B1
Authority
CU
Cuba
Prior art keywords
dibenzotiazepina
derivatives
Prior art date
Application number
CU20100252A
Other languages
Spanish (es)
Other versions
CU20100252A7 (en
Inventor
Dean Brown
James R Damewood
Phil Edwards
James Hulsizer
James Campbell Muir
Jr M Edward Pearson
Ashokkumar Bhikkappa Shenvi
Steven Wesolowski
Dan Widzowski
Michael Wood
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23884(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CU20100252A7 publication Critical patent/CU20100252A7/en
Publication of CU23884B1 publication Critical patent/CU23884B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CU20100252A 2008-06-20 2010-12-20 DERIVATIVES OF DIBENZOTIAZEPINA CU23884B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof

Publications (2)

Publication Number Publication Date
CU20100252A7 CU20100252A7 (en) 2011-11-15
CU23884B1 true CU23884B1 (en) 2013-04-19

Family

ID=41431860

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100252A CU23884B1 (en) 2008-06-20 2010-12-20 DERIVATIVES OF DIBENZOTIAZEPINA

Country Status (37)

Country Link
US (3) US20110160184A1 (en)
EP (1) EP2307389B1 (en)
JP (2) JP5468068B2 (en)
KR (1) KR20110019781A (en)
CN (1) CN102131791B (en)
AR (1) AR072200A1 (en)
AU (1) AU2009260905B2 (en)
BR (1) BRPI0914231A2 (en)
CA (1) CA2728675A1 (en)
CL (1) CL2010001471A1 (en)
CR (1) CR11860A (en)
CU (1) CU23884B1 (en)
CY (1) CY1113845T1 (en)
DK (1) DK2307389T3 (en)
DO (1) DOP2010000393A (en)
EA (1) EA201001889A1 (en)
EC (1) ECSP10010698A (en)
ES (1) ES2402084T3 (en)
HN (1) HN2010002683A (en)
HR (1) HRP20130234T1 (en)
IL (2) IL210081A (en)
ME (1) ME01516B (en)
MX (1) MX2010014203A (en)
MY (1) MY157518A (en)
NI (1) NI201000224A (en)
NZ (1) NZ590616A (en)
PE (1) PE20110029A1 (en)
PL (1) PL2307389T3 (en)
PT (1) PT2307389E (en)
RS (1) RS52703B (en)
SI (1) SI2307389T1 (en)
SV (1) SV2010003769A (en)
TW (1) TWI488854B (en)
UA (1) UA105903C2 (en)
UY (1) UY31919A (en)
WO (1) WO2009154563A1 (en)
ZA (1) ZA201100488B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME01516B (en) * 2008-06-20 2014-04-20 Astrazeneca Ab Dibenzothiazepine derivative and use thereof
KR102096550B1 (en) * 2013-08-12 2020-04-02 씨아이에스 맥스웰, 엘엘씨 Operating system integrated domain management
CN103524455A (en) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 2-chloro-10,11-Dihydro-11-oxodibenzo [b, f] [1, 4] thiazepine-11 (10-H)-one preparing method
CA2931289C (en) 2013-11-21 2023-10-17 Graphite Software Corporation Managed domains for remote content and configuration control on mobile information devices
CN104447615A (en) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 Preparation method of quetiapine intermediate
AU2024233659A1 (en) * 2023-03-08 2025-09-11 Johann Wolfgang Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL293201A (en)
NL294355A (en)
DE1620703B2 (en) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-BASIC SUBSTITUTED DIBENZO SQUARE BRACKET ON B, SQUARE BRACKET TO-SQUARE BRACKET ON 1.4 SQUARE BRACKET TO-THIAZEPINE
CH422793A (en) * 1961-07-20 1966-10-31 Wander Ag Dr A Process for the preparation of 11-basic substituted dibenzo (b, f) (1,4) thiazepines
DE1620713A1 (en) * 1962-05-25 1970-07-02 Wander Ag Dr A Process for the preparation of 11-basic substituted dibenzo [b, f] [1,4] thiazepines
CH476743A (en) 1962-06-08 1969-08-15 Wander Ag Dr A Process for the preparation of amidines of the dibenzo (b, e) (1,4) -diazepine series
NL140242B (en) * 1963-03-01 1973-11-15 Wander Ag Dr A METHOD FOR PREPARING THE 11-PLACE SUBSTITUTED DIBENZ (B.F.) (1.4) OXAZEPINES BY A BASIC GROUP.
BE632120A (en) 1963-05-09
US3908010A (en) * 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3683034A (en) * 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3884920A (en) * 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3412193A (en) * 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
US3444169A (en) * 1966-01-17 1969-05-13 American Cyanamid Co Process for 11 - aminodibenz(b,f)(1,4)oxazepines and analogous thiazepines
NL6715650A (en) 1966-12-16 1968-06-17
US3852446A (en) * 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
CH569731A5 (en) * 1972-04-04 1975-11-28 Wander Ag Dr A
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (en) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd Polycyclic compound
JPH0565257A (en) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd Polycyclic compound and its use
US5661184A (en) * 1994-08-12 1997-08-26 Eli Lilly And Company Psychiatric agents
PT777671E (en) 1994-08-24 2000-08-31 Astrazeneca Ab SPIRO-AZABICICLIC UTILITIES IN THERAPY
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (en) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (en) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (en) 1997-07-18 2000-12-13 Astrazeneca Ab SPYROZOBICYCLIC HETERO CYCLIC AMINES, PHARMACEUTICAL COMPOSITION, USE OF SUCH AMINES TO PREPARE MEDICINES AND METHOD OF TREATMENT OR PROPHYLAXIS
SE9702799D0 (en) 1997-07-25 1997-07-25 Astra Ab New compounds
US6342488B1 (en) * 1998-08-18 2002-01-29 Sepracor, Inc. Phosphonorisperidone and sulforisperidone compositions and methods
SE9900100D0 (en) 1999-01-15 1999-01-15 Astra Ab New compounds
JP2003505505A (en) 1999-07-28 2003-02-12 オスヴァルト・ヴィス Formulations to reduce oxygen consumption during exercise
SE9903760D0 (en) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (en) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
US6630462B2 (en) 2000-11-17 2003-10-07 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US7229994B2 (en) 2001-05-18 2007-06-12 Astrazeneca Ab 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
KR20040003021A (en) 2001-06-01 2004-01-07 아스트라제네카 아베 Novel Ligand for Nicotinic Acetylcholine Receptors Useful in Therapy
DE60233414D1 (en) 2001-07-09 2009-10-01 Combinatorx Inc COMBINATIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
MXPA04002912A (en) 2001-09-27 2004-07-05 Univ Ramot Conjugated anti-psychotic drugs and uses thereof.
US7417050B2 (en) 2002-04-18 2008-08-26 Astrazeneca Ab Heterocyclic compounds
ATE484508T1 (en) 2002-04-18 2010-10-15 Astrazeneca Ab FURYL COMPOUNDS
NZ535978A (en) 2002-04-18 2007-10-26 Astrazeneca Ab Novel spiroazabicyclic heterocyclic amines useful as nicotinic acetylcholine receptor agonists
SE0202430D0 (en) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202465D0 (en) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202598D0 (en) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
US20060111342A1 (en) 2002-09-18 2006-05-25 Argentine Joseph A Insecticidal tricyclic derivatives
AU2003290079A1 (en) 2002-12-20 2004-07-14 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
AU2004206931A1 (en) * 2003-01-23 2004-08-05 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine to treat human neuropsychiatric disease
CA2516646A1 (en) 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
DE10310196A1 (en) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Use a tricyclic antidepressant to promote endocytosis
ATE387435T1 (en) 2003-04-15 2008-03-15 Astrazeneca Ab SUBSTITUTED BENZOSULFONAMIDES AS POTENTIFIERS OF GLUTAMA RECEPTORS
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (en) 2003-07-18 2007-10-31 Helm Ag Method for manufacture of 11-(1-piperazinyl)dibenzo[b,f][1,4]thiazepine
CA2550735A1 (en) 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
RU2394030C2 (en) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. AMINOSUBSTITUTED DIARYL [a, d] CYCLOHEPTANE ANALOGUES AS MUSCARINIC AGONISTS AND METHOD OF TREATING PSYCHONEUROLOGICAL DISORDERS
US20060063754A1 (en) * 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
CN101128435A (en) 2004-12-27 2008-02-20 阿斯利康(瑞典)有限公司 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders
EP1838325A1 (en) * 2005-01-07 2007-10-03 AstraZeneca AB NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f][1,4]THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS
AU2006231497A1 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
JP2010514683A (en) 2006-12-20 2010-05-06 アストラゼネカ・アクチエボラーグ Compounds and uses thereof
US20110053953A1 (en) 2007-02-09 2011-03-03 Abdelmalik Slassi AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TWI417100B (en) 2007-06-07 2013-12-01 Astrazeneca Ab Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators-842
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
ME01516B (en) * 2008-06-20 2014-04-20 Astrazeneca Ab Dibenzothiazepine derivative and use thereof

Also Published As

Publication number Publication date
JP2011524898A (en) 2011-09-08
EP2307389A4 (en) 2012-04-11
US20110160184A1 (en) 2011-06-30
AU2009260905B2 (en) 2012-08-23
BRPI0914231A2 (en) 2015-11-03
EP2307389A1 (en) 2011-04-13
ME01516B (en) 2014-04-20
JP5468068B2 (en) 2014-04-09
UA105903C2 (en) 2014-07-10
HRP20130234T1 (en) 2013-04-30
DK2307389T3 (en) 2013-04-02
MX2010014203A (en) 2011-02-22
AR072200A1 (en) 2010-08-11
HN2010002683A (en) 2013-01-15
US20120202991A1 (en) 2012-08-09
US8653257B2 (en) 2014-02-18
CN102131791B (en) 2014-12-24
CU20100252A7 (en) 2011-11-15
EA201001889A1 (en) 2011-08-30
IL229560A (en) 2015-07-30
ZA201100488B (en) 2011-10-26
PE20110029A1 (en) 2011-02-11
KR20110019781A (en) 2011-02-28
SI2307389T1 (en) 2013-04-30
US20090318415A1 (en) 2009-12-24
NI201000224A (en) 2012-03-19
NZ590616A (en) 2012-09-28
MY157518A (en) 2016-06-15
US8158618B2 (en) 2012-04-17
CA2728675A1 (en) 2009-12-23
HK1156308A1 (en) 2012-06-08
TWI488854B (en) 2015-06-21
CY1113845T1 (en) 2016-07-27
IL210081A (en) 2013-12-31
DOP2010000393A (en) 2011-01-31
IL210081A0 (en) 2011-02-28
EP2307389B1 (en) 2013-01-23
IL229560A0 (en) 2014-01-30
TW201002702A (en) 2010-01-16
CR11860A (en) 2011-02-25
AU2009260905A1 (en) 2009-12-23
PT2307389E (en) 2013-03-28
UY31919A (en) 2010-01-29
SV2010003769A (en) 2011-05-20
ECSP10010698A (en) 2011-01-31
JP2014098006A (en) 2014-05-29
WO2009154563A1 (en) 2009-12-23
ES2402084T3 (en) 2013-04-26
PL2307389T3 (en) 2013-05-31
RS52703B (en) 2013-08-30
CN102131791A (en) 2011-07-20
CL2010001471A1 (en) 2011-05-06

Similar Documents

Publication Publication Date Title
DK2308877T3 (en) Imidazopyridine-2-one derivatives
BRPI1013246A2 (en) benzofuralin derivatives
BR112012002828A2 (en) 5-fluorpyrimidinone derivatives
BRPI0915064A2 (en) qunoxalinadione derivatives
DOP2007000084A (en) DERIVATIVES OF DIHYDROPIRAZOLOPIRIMIDINONE
BRPI0913832A2 (en) pyrrolopyridinylpyrimidin-2-ylamine derivatives
ECSP12011999A (en) SUBSTITUTED BENZAMIDA DERIVATIVES
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE
EP2380877A4 (en) PYRIDINE-3-CARBOXYAMIDE DERIVATIVE
EP2462134A4 (en) N1-SULFONYL-5-FLUOROPYRIMIDINONE DERIVATIVES
BR112012015868A2 (en) imidazolidinedione derivatives
HRP20150477T8 (en) PROCEDURES FOR OBTAINING KINAZOLONE DERIVATIVES
EP2124523A4 (en) LINE OF LITTLE P2428-5006090
BRPI1013844A2 (en) pyridine-isoxazole derivatives
EP2433940A4 (en) SPIROIMIDAZOLONE DERIVATIVE
DK2397480T3 (en) DIAZEPINDION DERIVATIVES
EP2336132A4 (en) MORPHOLINOPURIN DERIVATIVE
CR10562A (en) NEW DERIVATIVES OF PIRIDAZINA
DK2275414T3 (en) CYCLOPENTYLACRYLAMIDE DERIVATIVES
DK2335031T3 (en) IN-LINE-GAUGE
CR10809A (en) DERIVATIVES OF HETEROARIL-PIRROLIDINIL-Y-PIPERIDINIL-CETONA
BRPI1014454A2 (en) isoxazol-pyrazole derivatives
EP2349335A4 (en) IMMUNODOSAGES OF LÉVÉTIRACÉTAM
ATE545635T1 (en) SUBSTITUTED N-OXIDEPYRAZINE DERIVATIVES
BRPI0913234A2 (en) thiazolylpiperidine derivatives

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)